Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women. (4th March 2017)
- Record Type:
- Journal Article
- Title:
- Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women. (4th March 2017)
- Main Title:
- Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women
- Authors:
- Gaydos, CA
Schwebke, J
Dombrowski, J
Marrazzo, J
Coleman, J
Silver, B
Barnes, M
Crane, L
Fine, P - Abstract:
- ABSTRACT: Background: Solana® (Quidel) is a new rapid (<40 min.) point-of-care (POC) test for qualitative detection of Trichomonas vaginalis (TV) DNA. The assay has two steps: 1) specimen preparation, and 2) amplification and detection using isothermal Helicase-Dependent Amplification (HDA). The objective was to demonstrate the performance of Solana for vaginal swabs and female urines based on comparison to wet mount and TV culture. Performance was also compared to the Aptima-TV assay. Methods: Urine and four clinician-collected vaginal swabs were collected. The first two were used for FDA composite reference (wet mount; InPouch TV Culture). The third swab was used for Solana. Sensitivity/specificity were based on the reference method. A specimen was considered positive if either test was positive. The fourth swab was for Aptima-TV. Results: Vaginal swabs and urines were obtained from 501 asymptomatic and 543 symptomatic women. Prevalence of TV by was 11.5%. For swabs, Solana® demonstrated high sensitivity and specificity from asymptomatic (100%/98.9%) and symptomatic (98.6%/98.5%) women, as well as for urines from asymptomatic (98.0%/98.4%) and symptomatic (92.9%/97.9%) women, compared to the reference method. Compared to Aptima-TV, the sensitivity/specificity was 89.7%/99.0% for swabs and 100%/98.9% for urines. Conclusion: The Solana® assay performed well compared to the reference assays.
- Is Part Of:
- Expert review of molecular diagnostics. Volume 17:Number 3(2017)
- Journal:
- Expert review of molecular diagnostics
- Issue:
- Volume 17:Number 3(2017)
- Issue Display:
- Volume 17, Issue 3 (2017)
- Year:
- 2017
- Volume:
- 17
- Issue:
- 3
- Issue Sort Value:
- 2017-0017-0003-0000
- Page Start:
- 303
- Page End:
- 306
- Publication Date:
- 2017-03-04
- Subjects:
- Trichomonas vaginalis -- trichomoniasis -- point-of-care test -- Solana
Molecular diagnosis -- Periodicals
616.0758205 - Journal URLs:
- http://informahealthcare.com/toc/ero/current ↗
http://www.future-drugs.com/loi/erm ↗
http://www.tandfonline.com/toc/iero20/current ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14737159.2017.1282823 ↗
- Languages:
- English
- ISSNs:
- 1473-7159
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002987
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 2371.xml